Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Avicanna ( (TSE:AVCN) ) just unveiled an update.
Avicanna’s subsidiary Santa Marta Golden Hemp SAS has completed its first commercial export of CBG-dominant, organic-certified cannabis flower to Australia, marking the 21st international market for SMGH and the 24th for Avicanna’s products globally. This milestone underscores the company’s growing international footprint in medical cannabis and its capability to navigate complex regulatory environments.
The shipment leverages SMGH’s GACP and USDA organic-certified operations in Colombia, where year-round equatorial cultivation, controlled environments and a registered genetics portfolio support consistent, cost-efficient production of cannabinoid-specific chemotypes. By expanding exports of its proprietary CBG cultivar under the Aureus brand, Avicanna strengthens its position as a global supplier of standardized cannabis APIs, reinforcing its supply chain for its own product lines and broadening its role as a raw material provider to international partners.
The most recent analyst rating on (TSE:AVCN) stock is a Hold with a C$0.19 price target. To see the full list of analyst forecasts on Avicanna stock, see the TSE:AVCN Stock Forecast page.
Spark’s Take on AVCN Stock
According to Spark, TipRanks’ AI Analyst, AVCN is a Neutral.
The score is held back primarily by continued losses and negative cash flow despite strong revenue growth and improving gross margins, plus a weak technical trend (price below major moving averages and negative MACD). Valuation also screens poorly due to the negative P/E, consistent with the lack of current profitability.
To see Spark’s full report on AVCN stock, click here.
More about Avicanna
Avicanna Inc. is a Toronto-based, commercial-stage international biopharmaceutical company focused on developing, manufacturing and commercializing plant-derived, cannabinoid-based products for global medical and pharmaceutical markets. Through its majority-owned Colombian subsidiary Santa Marta Golden Hemp SAS, operating under the Aureus brand, it produces organic-certified cannabis raw materials and APIs, including CBD, CBG and THC, supplying internal product lines and third-party industries across more than 20 international markets.
Average Trading Volume: 53,655
Technical Sentiment Signal: Sell
Current Market Cap: C$19.48M
For an in-depth examination of AVCN stock, go to TipRanks’ Overview page.